 
                    XPROdox-CV
                            Type:
                            Tablet                        
                        
                        
                            Pack:
                            10x1x10                        
                        
                            Packing:
                            Alu Alu                         
                        
                            Category:
                            ANTIBIOTICS / ANTIVIRALS / ANTIPARASITIC                        
                        
                            Price:
                            ₹3,900.00                        
                        Contact Us to Purchase
                    Composition Details
Cefpodoxime 200mg + Clavulanic Acid 125mg
Description & Effects
XPROdox-CV is a combination antibiotic tablet containing Cefpodoxime Proxetil (200 mg) and Clavulanic Acid (125 mg), used to treat respiratory tract infections affecting the sinuses, throat, airways, or lungs. These infections are caused by bacteria, and this medicine works by targeting and eliminating the bacteria responsible.Cefpodoxime Proxetil works by stopping the growth of bacteria, preventing them from multiplying and spreading. Clavulanic Acid enhances the effectiveness of Cefpodoxime by reducing bacterial resistance, allowing the antibiotic to work more efficiently against bacteria that might otherwise survive treatment.
Patients usually start feeling better within a few days of starting XPROdox-CV. However, it is important to complete the full course of the medication as prescribed, even if symptoms improve early. Stopping treatment too soon can allow bacteria to survive and become resistant, making future infections harder to treat.
Always follow your doctor’s instructions regarding dosage and duration, and consult them if symptoms persist or worsen. Common side effects may include gastrointestinal discomfort, nausea, or allergic reactions.
 
                     
             
                                 
                                